The International IVF Initiative - i3


International IVF Initiative



3pm ET/ 8pm UK/ 9pm CET, Tuesday 23rd April 2024.

Dr. Rita Vassena

Dr. Vassena is the co-founder and director of Fecundis, a company dedicated to the development of innovative treatments for infertility. Before this position, Dr.Vassena has been the global Scientific Director of the Eugin Group. She has more than 20 years of experience in the field of reproduction with more than 120 publications in peer reviewed international journals and book chapters. Dr.Vassena is also a two-terms former member of the Executive Committee of ESHRE (European Society for Human Reproduction and Embryology), the largest international scientific society dedicated to human reproduction and embryology. She currently serves on the Executive Committee of the Spanish Fertility Society and is an advisor to several startup companies in the fertility space.

Dr. Kathy Miller

The author of more than 100 abstracts, papers and chapters on fertility and ART. Dr. Miller is known for research advances in the field of blastocyst culture, PGT and AI as well as a leading expert in laboratory management, QI programs, and single embryo transfer. Since 2014, she has been the managing editor of the IFFS Surveillance initiated in 1998 by Drs. Howard Jones, Jr. and Jean Cohen, assessing global practices of ART.

Dr. Miller is also the Chief Scientific Officer of Innovation Fertility/MedTech For Solutions and leads the laboratory team specializing in the implementation of cutting-edge ART technologies, laboratory management and state of the art laboratory design and build out. In 2017, Dr. Miller created the OvaTools Training Institute in Fort Lauderdale. The Institute provides academic and theoretical knowledge in ART and genetics with hands-on technical training in a focused and supervised learning environment at the ART training facility.

Dr. Sergio Papier

Dr. Papier is a Reproductive Medicine Specialist and Medical Director at the Cegyr and Novagen.
Director of the executive committee of the Latin-American Association of Reproductive Medicine (ALMER).
Past President of the Argentinian Society of Reproductive Medicine (SAMER) and the Latin-American Association of
Reproductive Medicine (ALMER).

Dr. Danilo Cimadomo

Dr Cimadomo is Innovation in Embryology Director and Science and Research manager Italy of IVIRMA Global Research Alliance. He has authored >130 papers. He is Basic Science officer and Coordinator Elect of the ESHRE SIG Implantation and Early Pregnancy, Associate Editor of Human Reproduction and Section Editor in Clinical Embryology of Reproductive BioMedicine Online. He participated to the ESHRE working groups updating the GPRs for embryo biopsy, and for RIF management. He coordinates the Master “Biology and Biotechnology of Reproduction: from Research to Clinics” at the University of Pavia.

Jullin Fjeldstad

Jullin Fjeldstad began her fertility career at the Victoria Fertility Centre in 2007, quickly becoming a senior embryologist and successfully holding the position of laboratory director for several years. She has a BSc. in Biology from the University of Victoria, Canada and a MSc. in Clinical Embryology from the University of Leeds, UK; achieving distinction in both areas. She has always held a passion for innovative ART technologies aimed to improve the fertility journey and patient IVF outcomes. Today, Jullin is the Head of Clinical Embryology and Scientific Operations for Future Fertility. She works closely with partnering clinics to ensure smooth onboarding of innovative AI-based tools within their laboratories. Additionally, she oversees Future Fertility’s scientific project collaborations, bringing research findings to international fertility conferences.

Dr. Molly Johnson

Dr Molly Johnston is an early-career research fellow at the Monash Bioethics Centre, Monash University, Australia. Molly has a background in reproductive science but her current research falls within the intersection between social science, bioethics, and regulation.

Molly is currently working on projects that address the ethical, social, and regulatory aspects of technology innovation in human reproduction, including non-invasive prenatal testing (NIPT); egg freezing, disposition and donation; the use of machine learning for embryo assessment in assisted reproduction; and mitoHOPE, the clinical trial for mitochondrial donation in Australia.

Molly has presented at 20+ academic meetings, with seven of these international and eight by invitation. She frequently contributes to industry forums and public discussions on matters related to (in)fertility, egg freezing, and egg donation.



Open tab

Customer Reviews

Based on 1 review Write a review
Close (esc)


Members get free stuff and can stay up to date with the latest sessions from I3.

Become a Member

Age verification

By clicking enter you are verifying that you are old enough to consume alcohol.


Shopping Cart

Your cart is currently empty.
Shop now